Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury

GLIA

Volumn 65, Issue 7, 2017, Pages 1152-1175

  Alizadeh, Arsalan ^a   Dyck, Scott M ^a   Kataria, Hardeep ^a   Shahriary, Ghazaleh M ^a   Nguyen, Dung H ^a   Santhosh, Kallivalappil T ^a   Karimi Abdolrezaee, Soheila ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

functional recovery; glial scar; IL 10; neuregulin 1; neuroinflammation; spinal cord injury

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GELATINASE A; GELATINASE B; HETERODIMER; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOID DIFFERENTIATION FACTOR 88; NEU DIFFERENTIATION FACTOR; NITRIC OXIDE; PROTEOCHONDROITIN SULFATE; RECOMBINANT GROWTH FACTOR; RECOMBINANT NEUREGULIN 1; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; TYROSINE; UNCLASSIFIED DRUG; ARGINASE; ARGINASE I, RAT; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CONTROLLED STUDY; CONVALESCENCE; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; FEMALE; GLIA CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; INJURY SEVERITY; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SCAR FORMATION; SPINAL CORD; SPINAL CORD INJURY; TISSUE PRESERVATION; ANIMAL; C57BL MOUSE; CELL CULTURE; COMPLICATION; CONDITIONED MEDIUM; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GLIA; LOCOMOTION; METABOLISM; NEUROLOGIC DISEASE; NEWBORN; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR;

ANIMALS; ANIMALS, NEWBORN; ARGINASE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LOCOMOTION; MICE; MICE, INBRED C57BL; NERVOUS SYSTEM DISEASES; NEUREGULIN-1; NEUROGLIA; RATS; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES; TIME FACTORS;

EID: 85018977940     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.23150     Document Type: Article

References (98)

1. Akira, S., & Takeda, K. (2004). Toll-like receptor signalling. Nature Reviews Immunology, 4, 499–511.
2. Alizadeh, A., Dyck, S. M., & Karimi-Abdolrezaee, S. (2015). Myelin damage and repair in pathologic CNS: Challenges and prospects. Frontiers in Molecular Neuroscience, 8, 35.
3. Allen, J. W., Mutkus, L. A., & Aschner, M. (2001). Isolation of neonatal rat cortical astrocytes for primary cultures. Current Protocols in Toxicology, Chapter 12, Unit12 4.
4. Babcock, A. A., Toft-Hansen, H., & Owens, T. (2008). Signaling through MyD88 regulates leukocyte recruitment after brain injury. Journal of Immunology, 181, 6481–6490.
5. Balasingam V., & Yong, V. W. (1996). Attenuation of astroglial reactivity by interleukin-10. Journal of Neuroscience, 16, 2945–2955.
6. Bartus, K., Galino, J., James, N. D., Hernandez-Miranda, L. R., Dawes, J. M., Fricker, F. R., … Garratt, A. N. (2016). Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury. Brain, 139, 1394–1416.
7. Beattie, M. S., Hermann, G. E., Rogers, R. C., & Bresnahan, J. C. (2002). Cell death in models of spinal cord injury. Progression in Brain Research, 137, 37–47.
8. Black, P., Markowitz, R. S., Cooper, V., Mechanic, A., Kushner, H., Damjanov, I., … Finkelstein, S. D. (1986). Models of spinal cord injury: Part 1. Static load technique. Neurosurgery, 19, 752–762.
9. Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., … (2002). Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature, 416, 636–640.
10. Brewer, K. L., Bethea, J. R., & Yezierski, R. P. (1999). Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Experimental Neurology, 159, 484–493.
11. Bruce, J. C., Oatway, M. A., & Weaver, L. C. (2002). Chronic pain after clip-compression injury of the rat spinal cord. Experimental Neurology, 178, 33–48.
12. Calvo, M., Zhu, N., Grist, J., Ma, Z., Loeb, J. A., & Bennett, D. L. (2011). Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. Glia, 59, 554–568.
13. Casha, S., Yu, W., & Fehlings, M. (2001). Oligodendrocyte apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience, 103, 203–218.
14. Chang, C. I., Liao, J. C., & Kuo, L. (1998). Arginase modulates nitric oxide production in activated macrophages. American Journal of Physiology, 274, H342–H348.
15. Chanteux, H., Guisset, A. C., Pilette, C., & Sibille, Y. (2007). LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. Respiratory Research, 8, 71.
16. Chen, M., Bi, L. L., Wang, Z. Q., Zhao, F., Gan, X. D., & Wang, Y. G. (2013). Time-dependent regulation of neuregulin-1beta/ErbB/ERK pathways in cardiac differentiation of mouse embryonic stem cells. Molecular & Cellular Biochemistry, 380, 67–72.
17. Chen, Y. J., Johnson, M. A., Lieberman, M. D., Goodchild, R. E., Schobel, S., Lewandowski, N., … Rosoklija, G. (2008). Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. Journal of Neuroscience, 28, 6872–6883.
18. Conti, A., Miscusi, M., Cardali, S., Germano, A., Suzuki, H., Cuzzocrea, S., … Tomasello, F. (2007). Nitric oxide in the injured spinal cord: Synthases cross-talk, oxidative stress and inflammation. Brain Research & Review, 54, 205–218.
19. Corraliza, I. M., Soler, G., Eichmann, K., & Modolell, M. (1995). Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochemical & Biophysical Research Communications, 206, 667–673.
20. David, S., & Kroner, A. (2011). Repertoire of microglial and macrophage responses after spinal cord injury. Nature Reviews Neuroscience, 12, 388–399.
21. Donnelly, D. J., & Popovich, P. G. (2008). Inflammation and its role in neuroprotection., axonal regeneration and functional recovery after spinal cord injury. Experimental Neurology, 209, 378–388.
22. Dyck, S. M., Alizadeh, A., Santhosh, K. T., Proulx, E. H., Wu, C. L., & Karimi-Abdolrezaee, S. (2015). Chondroitin sulfate proteoglycans negatively modulate spinal cord neural precursor cells by signaling through LAR and RPTPsigma and modulation of the Rho/ROCK pathway. Stem Cells, 33, 2550–2563.
23. Dyck, S. M., & Karimi-Abdolrezaee, S. (2015). Chondroitin sulfate proteoglycans: Key modulators in the developing and pathologic central nervous system. Experimental Neurology, 269, 169–187.
24. Facci, L., Barbierato, M., Marinelli, C., Argentini, C., Skaper, S. D., & Giusti, P. (2014). Toll-like receptors 2, −3 and −4 prime microglia but not astrocytes across central nervous system regions for ATP-dependent interleukin-1beta release. Science Reports, 4, 6824.
25. Falls, D. L. (2003). Neuregulins: functions, forms, and signaling strategies. Experimental Cell Research, 284, 14–30.
26. Ferguson, A. R., Christensen, R. N., Gensel, J. C., Miller, B. A., Sun, F., Beattie, E. C., … Bresnahan, J. C. (2008). Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. Journal of Neuroscience, 28, 11391–11400.
27. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O'Garra, A. (1991). IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology, 147, 3815–3822.
28. Fleming, J. C., Bao, F., Chen, Y., Hamilton, E. F., Relton, J. K., & Weaver, L. C. (2008). Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function. Experimental Neurology, 214, 147–159.
29. Gauthier, M.-K., Kosciuczyk, K., Tapley, L., & Karimi-Abdolrezaee, S. (2013). Dysregulation of the neuregulin-1-ErbB network modulates endogenous oligodendrocyte differentiation and preservation after spinal cord injury. European Journal of Neuroscience, 38, 2693–2715.
30. Hamby, M. E., & Sofroniew, M. V. (2010). Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics, 7, 494–506.
31. Hansen, C. N., Fisher, L. C., Deibert, R. J., Jakeman, L. B., Zhang, H., & Noble-Haeusslein, L. (2013). Elevated MMP-9 in the lumbar cord early after thoracic spinal cord injury impedes motor relearning in mice. Journal of Neuroscience, 33, 13101–13111.
32. Hausmann, O. N. (2003). Post-traumatic inflammation following spinal cord injury. Spinal Cord, 41, 369–378.
33. Hedrich, C. M., & Bream, J. H. (2010). Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunology & Research, 47, 185–206.
34. Hsu, J. Y., Bourguignon, L. Y., Adams, C. M., Peyrollier, K., Zhang, H., Fandel, T., … Cun, C. L. (2008). Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord. Journal of Neuroscience, 28, 13467–13477.
35. Hutchins, A. P., Diez, D., & Miranda-Saavedra, D. (2013). The IL-10/STAT3-mediated anti-inflammatory response: Recent developments and future challenges. Briefings in Functional Genomics, 12, 489–498.
36. Iwakura Y., & Nawa, H. (2013). ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: Pathological implications in schizophrenia and Parkinson's disease. Frontiers in Cell Neuroscience, 7, 4.
37. Karimi-Abdolrezaee, S., & Billakanti, R. (2012). Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Molecular Neurobiology, 46, 251–264.
38. Karimi-Abdolrezaee, S., Eftekharpour, E., Wang, J., Morshead, C. M., & Fehlings, M. G. (2006). Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. Journal of Neuroscience, 26, 3377–3389.
39. Karimi-Abdolrezaee, S., Eftekharpour, E., Wang, J., Schut, D., & Fehlings, M. G. (2010). Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. Journal of Neuroscience, 30, 1657–1676.
40. Karimi-Abdolrezaee, S., Schut, D., Wang, J., & Fehlings, M. G. (2012). Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury. Plos One, 7, 1–16.
41. Kielian, T. (2006). Toll-like receptors in central nervous system glial inflammation and homeostasis. Journal of Neuroscience & Research, 83, 711–730.
42. Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009). Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. Journal of Neuroscience, 29, 13435–13444.
43. Kigerl, K. A., Lai, W., Rivest, S., Hart, R. P., Satoskar, A. R., & Popovich, P. G. (2007). Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. Journal of Neurochemistry, 102, 37–50.
44. Klusman, I., & Schwab, M. E. (1997). Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Research, 762, 173–184.
45. Kovacs, T., Bansagi, B., Kelemen, O., & Keri, S. (2014). Neuregulin 1-induced AKT and ERK phosphorylation in patients with fragile X syndrome (FXS) and intellectual disability associated with obstetric complications. Journal of Molecular Neuroscience, 54, 119–124.
46. Kroner, A., Greenhalgh, A. D., Zarruk, J. G., Passos Dos Santos, R., Gaestel, M., & David, S. (2014). TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron, 83, 1098–1116.
47. Lang, R., Patel, D., Morris, J. J., Rutschman, R. L., & Murray, P. J. (2002). Shaping gene expression in activated and resting primary macrophages by IL-10. Journal of Immunology, 169, 2253–2263.
48. Lau, L. W., Keough, M. B., Haylock-Jacobs, S., Cua, R., Doring, A., Sloka, S., … Stirling, D. P. (2012). Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Annals of Neurology, 72, 419–432.
49. Ledeboer, A., Breve, J. J., Poole, S., Tilders, F. J., & Van Dam, A. M. (2000). Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia, 30, 134–142.
50. Lehnardt, S., Lachance, C., Patrizi, S., Lefebvre, S., Follett, P. L., Jensen, F. E., … Rosenberg, P. A. (2002). The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. Journal of Neuroscience, 22, 2478–2486.
51. Li, Q., Zhang, R., Guo, Y. L., & Mei, Y. W. (2009). Effect of neuregulin on apoptosis and expressions of STAT3 and GFAP in rats following cerebral ischemic reperfusion. Journal of Molecular Neuroscience, 37, 67–73.
52. Li, S., & Stys, P. K. (2000). Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. Journal of Neuroscience, 20, 1190–1198.
53. Li, Y., Lein, P. J., Ford, G. D., Liu, C., Stovall, K. C., White, T. E., … Bruun, D. A. (2015). Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury. Journal of Neuroinflammation, 12, 64.
54. Li, Y., Xu, Z., Ford, G. D., Croslan, D. R., Cairobe, T., Li, Z., … Ford, B. D. (2007). Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia. Brain Research, 1184, 277–283.
55. Liu, B. S., Cao, Y., Huizinga, T. W., Hafler, D. A., & Toes, R. E. (2014). TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. European Journal of Immunology, 44, 2121–2129.
56. Maddahi, A., & Edvinsson, L. (2010). Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. Journal of Neuroinflammation, 7, 14.
57. Marchant, A., Bruyns, C., Vandenabeele, P., Ducarme, M., Gerard, C., Delvaux, A., … De Groote, D. (1994). Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. European Journal of Immunology, 24, 1167–1171.
58. Marsala, J., Orendacova, J., Lukacova, N., & Vanicky, I. (2007). Traumatic injury of the spinal cord and nitric oxide. Progression in Brain Research, 161, 171–183.
59. Mei, L., & Xiong, W. C. (2008). Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nature Reviews Neuroscience, 9, 437–452.
60. Mencel, M., Nash, M., & Jacobson, C. (2013). Neuregulin upregulates microglial alpha7 nicotinic acetylcholine receptor expression in immortalized cell lines: Implications for regulating neuroinflammation. PLoS One, 8, e70338.
61. Miron, V. E., Boyd, A., Zhao, J. W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., … van Wijngaarden, P. (2013). M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nature Neuroscience, 16, 1211–1218.
62. Monje, P. V., Bartlett Bunge, M., & Wood, P. M. (2006). Cyclic AMP synergistically enhances neuregulin-dependent ERK and Akt activation and cell cycle progression in Schwann cells. Glia, 53, 649–659.
63. Mori, T., Wang, X., Jung, J. C., Sumii, T., Singhal, A. B., Fini, M. E., … Dixon, C. E. (2002). Mitogen-activated protein kinase inhibition in traumatic brain injury: In vitro and in vivo effects. Journal of Cerebral Blood Flow Metabolism, 22, 444–452.
64. Muzio, M., Ni, J., Feng, P., & Dixit, V. M. (1997). IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science, 278, 1612–1615.
65. Nesic, O., Xu, G. Y., McAdoo, D., High, K. W., Hulsebosch, C., & Perez-Pol, R. (2001). IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. Journal of Neurotrauma, 18, 947–956.
66. Noble, L. J., Donovan, F., Igarashi, T., Goussev, S., & Werb, Z. (2002). Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. Journal of Neuroscience, 22, 7526–7535.
67. Norden, D. M., Fenn, A. M., Dugan, A., & Godbout, J. P. (2014). TGFbeta produced by IL-10 redirected astrocytes attenuates microglial activation. Glia, 62, 881–895.
68. Pineau, I., Sun, L., Bastien, D., & Lacroix, S. (2010). Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behaviour & Immunity, 24, 540–553.
69. Puntambekar, S. S., Hinton, D. R., Yin, X., Savarin, C., Bergmann, C. C., Trapp, B. D., … Stohlman, S. A. (2015). Interleukin-10 is a critical regulator of white matter lesion containment following viral induced demyelination. Glia, 63, 2106–2120.
70. Ryzhov, S., Matafonov, A., Galindo, C., Zhang, Q., Tran, T.-L., Lenihan, D., … Geisberg Lenneman, C. (2015). Activation of ERBB3 receptor prevents TNFα production from human non-classical monocytes. The FASEB Journal, 29, 942–944.
71. Saraiva, M., Christensen, J. R., Veldhoen, M., Murphy, T. L., Murphy, K. M., & O'Garra, A. (2009). Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity, 31, 209–219.
72. Sato, A., Ohtaki, H., Tsumuraya, T., Song, D., Ohara, K., Asano, M., … Iwakura, Y. (2012). Interleukin-1 participates in the classical and alternative activation of microglia/macrophages after spinal cord injury. Journal of Neuroinflammation, 9, 65.
73. Saud, K., Herrera-Molina, R., & Von Bernhardi, R. (2005). Pro- and anti-inflammatory cytokines regulate the ERK pathway: Implication of the timing for the activation of microglial cells. Neurotoxicity Research, 8, 277–287.
74. Sharma, H. S., Westman, J., Olsson, Y., & Alm, P. (1996). Involvement of nitric oxide in acute spinal cord injury: An immunocytochemical study using light and electron microscopy in the rat. Neuroscience Research, 24, 373–384.
75. Simmons, L. J., Surles-Zeigler, M. C., Li, Y., Ford, G. D., Newman, G. D., & Ford, B. D. (2016). Regulation of inflammatory responses by neuregulin-1 in brain ischemia and microglial cells in vitro involves the NF-kappa B pathway. Journal of Neuroinflammation, 13, 237.
76. Sofroniew, M. V. (2005). Reactive astrocytes in neural repair and protection. Neuroscientist, 11, 400–407.
77. Sofroniew, M. V. (2009). Molecular dissection of reactive astrogliosis and glial scar formation. Trends in Neurosciences, 32, 638–647.
78. Su, Z., Yuan, Y., Chen, J., Zhu, Y., Qiu, Y., Zhu, F., … Huang, A. (2011). Reactive astrocytes inhibit the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-alpha. Journal of Neurotrauma, 28, 1089–1100.
79. Syed, N., Reddy, K., Yang, D. P., Taveggia, C., Salzer, J. L., Maurel, P., & Kim, H. A. (2010). Soluble neuregulin-1 has bifunctional, concentration-dependent effects on Schwann cell myelination. Journal of Neuroscience, 30, 6122–6131.
80. Szydlowska, K., Gozdz, A., Dabrowski, M., Zawadzka, M., & Kaminska, B. (2010). Prolonged activation of ERK triggers glutamate-induced apoptosis of astrocytes: neuroprotective effect of FK506. Journal of Neurochemistry, 113, 904–918.
81. Takahashi, J. L., Giuliani, F., Power, C., Imai, Y., & Yong, V. W. (2003). Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Annals of Neurology, 53, 588–595.
82. Talmage, D. A. (2008). Mechanisms of neuregulin action. Novartis Foundation & Symposium, 289, 74–84; discussion 84–93.
83. Tao, F., Li, Q., Liu, S., Wu, H., Skinner, J., Hurtado, A., … Belegu, V. (2012). Role of neuregulin-1/ErbB signaling in stem cell therapy for spinal cord injury-induced chronic neuropathic pain. Stem Cells, 31, 83–91.
84. Taveggia, C., Feltri, M. L., & Wrabetz, L. (2010). Signals to promote myelin formation and repair. Nature Reviews Neurology, 6, 276–287.
85. Thompson, C. D., Zurko, J. C., Hanna, B. F., Hellenbrand, D. J., & Hanna, A. (2013). The therapeutic role of interleukin-10 after spinal cord injury. Journal of Neurotrauma, 30, 1311–1324.
86. Tynyakov-Samra, E., Auriel, E., Levy-Amir, Y., & Karni, A. (2011). Reduced ErbB4 expression in immune cells of patients with relapsing remitting multiple sclerosis. Multiple Sclerosis International, 2011, 561262.
87. Vartanian, T., Fischbach, G., & Miller, R. (1999). Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proceedings of National Academic Sciences USA, 96, 731–735.
88. Vecil, G. G., Larsen, P. H., Corley, S. M., Herx, L. M., Besson, A., Goodyer, C. G., & Yong, V. W. (2000). Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. Journal of Neuroscience Research, 61, 212–224.
89. Wandinger, S. K., Lahortiga, I., Jacobs, K., Klammer, M., Jordan, N., Elschenbroich, S., … Parade, M. (2016). Quantitative phosphoproteomics analysis of ERBB3/ERBB4 signaling. PLoS One, 11, e0146100.
90. Wang, Y., Cheng, X., He, Q., Zheng, Y., Kim, D. H., Whittemore, S. R., & Cao, Q. L. (2011). Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. Journal of Neuroscience, 31, 6053–6058.
91. Wattananit, S., Tornero, D., Graubardt, N., Memanishvili, T., Monni, E., Tatarishvili, J., … Miskinyte, G. (2016). Monocyte-derived macrophages contribute to spontaneous long-term functional recovery after stroke in mice. Journal of Neuroscience, 36, 4182–4195.
92. Xu, Z., Croslan, D. R., Harris, A. E., Ford, G. D., & Ford, B. D. (2006). Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke. Journal of Cerebral Blood Flow Metabolism, 26, 527–535.
93. Yao, A. H., Jia, L. Y., Zhang, Y. K., Ma, Q. R., Cheng, P., Liu, L., & Ju, G. (2012). Early blockade of TLRs MyD88-dependent pathway may reduce secondary spinal cord injury in the rats. Evidence Based Complement Alternatative Medicine, 2012, 591298.
94. Yong, V. W., Power, C., Forsyth, P., & Edwards, D. R. (2001). Metalloproteinases in biology and pathology of the nervous system. Nature Reviews Neuroscience, 2, 502–511.
95. Yune, T. Y., Chang, M. J., Kim, S. J., Lee, Y. B., Shin, S. W., Rhim, H., … Kim, Y. C. (2003). Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats. Journal of Neurotrauma, 20, 207–219.
96. Zhang, B., Bailey, W. M., Braun, K. J., & Gensel, J. C. (2015). Age decreases macrophage IL-10 expression: Implications for functional recovery and tissue repair in spinal cord injury. Experimental Neurology, 273, 83–91.
97. Zhao, W. X. W., Le, W., Beers, D. R., He, Y., Henkel, J. S., Simpson, E. P., Yen, A. A., Xiao, Q., Appel, S. H. (2004). Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. Journal of Neuropathology & Experimental Neurology, 63, 964–977.
98. Zhou, Z., Peng, X., Insolera, R., Fink, D. J., & Mata, M. (2009). IL-10 promotes neuronal survival following spinal cord injury. Experimental Neurology, 220, 183–190.